4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-050225
Chief Medical Officer sold 4,167 shares at $40.00 ($166,680)
- Chief Medical Officer acquired 4,167 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BALDO LANCE · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-10 | Exercise or conversion : show line 1 in the form | +18 | $7.80 | $140 | 18 | D |
| 2020-09-10 | Sale : show line 2 in the form | −18 | $40.00 | $720 | 0 | D |
| 2020-09-11 | Exercise or conversion : show line 3 in the form | +4,149 | $7.80 | $32,362 | 4,149 | D |
| 2020-09-11 | Sale : show line 4 in the form | −4,149 | $40.00 | $165,960 | 0 | D |
| Open-market sales · 4,167 sh · avg $40.00 · $166,680 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-10 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −18 | 429,149 | D |
| 2020-09-11 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −4,149 | 425,000 | D |
Loading xslF345X03/doc4.xml…